We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
This advice sets out where and when it may be appropriate to prescribe liothyronine in the NHS for current and new patients with hypothyroidism, depression and thyroid cancer. It supports the safe, appropriate and cost-effective use of liothyronine to achieve the best outcomes for patients and ensure effective use of NHS resources.